Arden Trust CO Novartis Ag Transaction History

Arden Trust CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 23, 2021	SELL	$83.5 - $98.47 $1.45 Million - $1.71 Million	-17,376 Closed	0 $0
Q4 2020 Jan 15, 2021	SELL	$78.07 - $94.43 $15,067 - $18,224	-193 Reduced 1.1%	17,376 $1.64 Million
Q3 2020 Oct 15, 2020	SELL	$82.14 - $91.0 $224,817 - $249,067	-2,737 Reduced 13.48%	17,569 $1.53 Million
Q2 2020 Jul 09, 2020	SELL	$80.93 - $91.1 $172,219 - $193,860	-2,128 Reduced 9.49%	20,306 $1.77 Million
Q1 2020 Apr 16, 2020	BUY	$70.67 - $99.01 $15,052 - $21,089	213 Added 0.96%	22,434 $1.85 Million

Q4 2019 Jan 17, 2020	SELL	$84.35 - $95.37 $289,573 - $327,405	-3,433 Reduced 13.38%	22,221 $2.1 Million
Q3 2019 Oct 09, 2019	SELL	$85.54 - $94.26 $4,875 - $5,372	-57 Reduced 0.22%	25,654 $2.23 Million
Q2 2019 Jul 23, 2019	BUY	$75.4 - $92.8 $1.94 Million - $2.39 Million	25,711 New	25,711 $2.35 Million

1,350

140M

1.15M

866K

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $232B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Arden Trust CO, based on Form 13F filings with the SEC.

Stay updated on Arden Trust CO with notifications on news.